SARS-CoV-2 Vaccine Booster Elicits Robust Prolonged Maternal Antibody Responses and Passive Transfer Via The Placenta And Breastmilk.

Nicole E MarshallMadison B Blanton Brianna M DorattDelphine C MalherbeMonica RinconHeather TrueTaylor McdonaldCaroline BeauregardReuben AdatorwovorIlhem Messaoudi

Published in: bioRxiv : the preprint server for biology (2022)

via the placenta and after birth via breastfeeding. Maternal booster vaccination, regardless of gestational age at maternal vaccination, significantly increased antibody levels in breastmilk and maternal plasma, indicating the importance of this additional dose to maximize passive protection against SARS-CoV-2 infection for neonates and infants until vaccination eligibility.

Keyphrases

birth weight
gestational age
pregnancy outcomes
sars cov
preterm birth
weight gain
respiratory syndrome coronavirus
preterm infants